85 related articles for article (PubMed ID: 10200534)
1. Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation.
Haas JP; Grunke M; Frank C; Kolowos W; Dirnecker D; Leipold G; Hieronymus T; Lorenz HM; Herrmann M
Cell Death Differ; 1998 Sep; 5(9):751-7. PubMed ID: 10200534
[TBL] [Abstract][Full Text] [Related]
2. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.
Drappa J; Vaishnaw AK; Sullivan KE; Chu JL; Elkon KB
N Engl J Med; 1996 Nov; 335(22):1643-9. PubMed ID: 8929361
[TBL] [Abstract][Full Text] [Related]
3. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
4. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
Nagata S
J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations.
Vaishnaw AK; Toubi E; Ohsako S; Drappa J; Buys S; Estrada J; Sitarz A; Zemel L; Chu JL; Elkon KB
Arthritis Rheum; 1999 Sep; 42(9):1833-42. PubMed ID: 10513797
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune lymphoproliferative syndrome in a patient with common variable immunodeficiency: dichotomy of apoptosis.
Narra MB; Abdou NI
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):585-8. PubMed ID: 17601274
[TBL] [Abstract][Full Text] [Related]
7. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Holzelova E; Vonarbourg C; Stolzenberg MC; Arkwright PD; Selz F; Prieur AM; Blanche S; Bartunkova J; Vilmer E; Fischer A; Le Deist F; Rieux-Laucat F
N Engl J Med; 2004 Sep; 351(14):1409-18. PubMed ID: 15459302
[TBL] [Abstract][Full Text] [Related]
9. Investigation of suspected deficient Fas-mediated apoptosis in a father and son.
Hanlon MG; Gacis ML; Kakakios AM; Kilham H
Cytometry; 2001 Mar; 43(3):195-8. PubMed ID: 11170106
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
[TBL] [Abstract][Full Text] [Related]
11. A new disorder of lymphocyte apoptosis: combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death.
Hundt M; Posovszky C; Schmidt RE
Immunobiology; 2002 Dec; 206(5):514-8. PubMed ID: 12607726
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
13. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
Kaser A; Nagata S; Tilg H
Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
[TBL] [Abstract][Full Text] [Related]
14. Impaired apoptosis of lymphocytes derived from patient with decreased expression of caspase-8 results in Alps-like phenotype.
Grzela T; Krauze A; Grzela K; Lazarczyk M; Niderla J; Brawura-Biskupski-Samaha R; Dziunycz P; Milewski L; Korczak-Kowalska G; Kulus M
Int J Mol Med; 2004 Nov; 14(5):937-42. PubMed ID: 15492869
[TBL] [Abstract][Full Text] [Related]
15. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
Büssing A; Stein GM; Pfüller U; Schietzel M
Anticancer Res; 1999; 19(3A):1785-90. PubMed ID: 10470116
[TBL] [Abstract][Full Text] [Related]
16. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.
Siegel RM; Chan FK; Chun HJ; Lenardo MJ
Nat Immunol; 2000 Dec; 1(6):469-74. PubMed ID: 11101867
[TBL] [Abstract][Full Text] [Related]
17. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene.
Gualco G; van den Berg A; Koopmans S; Bacchi LM; Carneiro SS; Ruiz E; Vecchi AP; Chan JK
Hum Pathol; 2008 Jan; 39(1):137-41. PubMed ID: 18070632
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.
Bosque A; Aguiló JI; del Rey M; Paz-Artal E; Allende LM; Naval J; Anel A
J Leukoc Biol; 2008 Aug; 84(2):488-98. PubMed ID: 18483205
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.
Tighe PJ; Stevens SE; Dempsey S; Le Deist F; Rieux-Laucat F; Edgar JD
Genes Immun; 2002 Oct; 3 Suppl 1():S66-70. PubMed ID: 12215906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
